PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the How
Visit https://www.peervoice.com/SXQ860 to view the entire programme with slides. After completing “Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the How”, participants will be able to: Evaluate the current guideline-recommended place of basal insulin therapy in the management of type 2 diabetes mellitus (T2DM); Identify common contributors to delayed initiation of basal insulin treatment for patients with T2DM; and Analyse current efficacy and safety data for once-weekly insulins in the management of T2DM.